Patients with cancer, especially blood cancer, have low protection against the Delta variant but will benefit from a third dose of COVID-19 vaccine
A third dose of the COVID-19 vaccine could increase protection from COVID-19 for people with cancer, and especially blood cancer, according to a new study from the Crick and The Royal Marsden NHS Foundation Trust
Published: 27 October 2021